Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03935997 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Implementing, Evaluating, and Scaling Up of the Strengthening a Palliative Approach in Long Term Care (SPA-LTC) Program

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary endpoints: details revised at 1 of 1 entry Completion pushed from Jan 31, 2026 to Jan 31, 2028 · Secondary endpoints: details revised at 2 of 7 entries · Publications: details revised at 5 of 5 entries · 1 more Show 4 more changesShow less
    • Completion pushed from Jan 31, 2026 to Jan 31, 2028
    • Secondary endpoints: details revised at 2 of 7 entries
    • Publications: details revised at 5 of 5 entries
    • Eligibility criteria expanded, about 3 words
  2. Completion date: Jan 31, 2025 to Jan 31, 2026v9
  3. Collaborators reorderedv8
  4. Primary and study completion dates: Jan 31, 2024 to Jan 31, 2025 Trial status: Recruiting to Active, Not Recruiting · Site details revised at 4 of 4 sitesv7 Show 2 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 4 of 4 sites
  5. Trial status: Not Yet Recruiting to Recruiting Enrollment target: 396 to 594 · Start date changed from estimate of Jan 1, 2022 to Jun 1, 2022 · Study sites: 0 to 4 · 4 morev6 Show 7 more changesShow less
    • Enrollment target: 396 to 594
    • Start date changed from estimate of Jan 1, 2022 to Jun 1, 2022
    • Study sites: 0 to 4
    • Primary and study completion dates: Jun 30, 2024 to Jan 31, 2024
    • Secondary endpoints: 9 to 7
    • Study description revised
    • Study arms: 3 to 2

    See this version in full on ClinicalTrials.gov ↗

Show 4 earlier versionsHide 4 earlier versions
  1. Start date: Sep 1, 2021 to Jan 1, 2022v5
  2. Start date: Jan 1, 2021 to Sep 1, 2021v4
  3. Enrollment target: 594 to 396 Primary completion date: May 1, 2023 to Jun 30, 2024 · Start date: May 1, 2019 to Jan 1, 2021 · Primary endpoint revised · 5 morev3 Show 8 more changesShow less
    • Primary completion date: May 1, 2023 to Jun 30, 2024
    • Start date: May 1, 2019 to Jan 1, 2021
    • Primary endpoint revised
    • Completion date: May 1, 2024 to Jun 30, 2024
    • Eligibility criteria expanded, about 25 words
    • Secondary endpoints: 5 to 9
    • Study description expanded, about 8 words
    • Study arms: 6 to 3

    See this version in full on ClinicalTrials.gov ↗

  4. Secondary endpoints: details revised at 3 of 5 entries Study description expanded, about 1 wordv2 Show 1 more changeShow less
    • Study description expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will evaluate the implementation of the Strengthening a Palliative Approach in Long-Term Care (SPA-LTC) program using a cross-jurisdictional, effectiveness-implementation type II hybrid design (dual testing of clinical and implementation interventions) to assess the implementation (feasibility, fidelity, reach, sustainability) and effectiveness (family satisfaction, staff knowledge and confidence implementing a palliative approach to care, hospital use).
Trial Details
NCT Number NCT03935997
Lead Sponsor McMaster University
Collaborators: Alberta Health services, Hospice Palliative Care Ontario, Canadian Hospice Palliative Care Association, Canadian Virtual Hospice, Saskatchewan Health Authority - Regina Area, Interlake-Eastern Regional Health Authority
Conditions Frail Elderly Syndrome
Enrollment 594 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov